Today, on 8 July, the Annual Report and the Corporate Social Responsibility Report 2013 of JSC Grindeks were submitted to “Nasdaq OMX Riga”. JSC Grindeks...
JSC Grindeks informs that its new Quality Control Laboratory was ceremonially opened today, on 5 June; it is one of the most advanced laboratories in...
Today, on 30 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2014 to “Nasdaq OMX Riga”. Non-audited financial...
Today, on 30 April, JSC Grindeks has submitted the audited consolidated financial statements for 2013 to “Nasdaq OMX Riga”. Audited financial results show that the...
From 22 to 24 October, 2013, Grindeks participates in the leading pharmaceutical exhibition “CPhI Worldwide 2013” in Frankfurt, Germany. During the exhibition Grindeks will meet...
The management system of JSC Grindeks has received the Russian ГОСТ (GOST) certificate of quality ISO 9001-2011. This was reported by representatives of the company....
JSC Grindeks is pleased to announce the successful passing of the U.S. Food and Drug Administration inspection. The issued certification paves the way for Grindeks...
JSC Grindeks was named among 25 most influental Latvian exporting enterprises. The award ceremony was organised by the society for Latvian exporters’ support, “The Red...
JSC Grindeks informs that according to the decision taken at the shareholder meeting, the company will keep the yearly profit undivided and will not distribute...
JSC Grindeks was included in the list of the top-100 most influential Latvian export enterprises. Corresponding information was put together in a research paper, prepared...
JSC Grindeks was named among 25 most influental Latvian exporting enterprises. The award ceremony was organised by the society for Latvian exporters’ support, “The Red...
On 28 February, JSC Grindeks submitted the non-audited consolidated financial statements for 2012 to “Nasdaq OMX Riga”. Non-audited financial results show the turnover of the...
